- Industry Left Col
- Industry Right Col
UI Developer Role
What is ui developer role?
A UI developer’s role is to translate creative software design concepts and ideas into reality using front end technology. They understand the user interface design solution both in its practical intent and creative vision, and convert it into engineered softwares. A UI Developer is the bridge between presentation layer and the backend layer, who understands both and creates a niche as the translational layer in between, so that both lives up to its full potential and are not compromised because of each other.
The task of a user experience designer is to design and create a software interfaces by prioritizing Users and business requirements over technology limitations and constraints. The UI developer, participates in the design process as a consultant on possibilities, takes the design that is created by the UX Designer as an input, understands it, knows enough to appreciate it, work through the constraints and execute the design vision into engineered reality.
Their role needs the following skills:
- A level of design and business understanding so as to not compromise on business goals and design intents
HR Executives today are under significant pressure to demonstrate their contribution to their organization’s strategic goals. They are now looking for opportunities to take a business leadership role that goes beyond the people strategy. There is both the desire and the need to demonstrate and improve the value delivered by HR. Critically this change is occurring at a time of intense competition and globalization. In addition the impact of the so called “Generation Y” and developments in social uses of technology are driving the need for different approaches in workforce management and organizational structures.
iGovern™ Unemployment Insurance
The customer is a US-based Integrated Logistics provider with operations spread across the globe.
UI Strategy Execution for a Global Logistics Provider
The Food and Drug Administration Amendments Act (FDAAA) of 2007 signed on September 27, 2007 authorizes the Food and Drug Administration (FDA) to require manufacturers to submit a proposed Risk Evaluation and Mitigation Strategy (REMS) if the FDA determines that REMS is necessary to ensure that the benefits of the drug or biological product outweigh the risks. The act took effect on March 25, 2008 and it applies to applications submitted under Food and Drug Cosmetics Act (FDCA) subsection 505 (b) or (j) and applications submitted under section 351 of the Public Health. These applications are termed covered applications and refer to new drug applications (NDAs), abbreviated new drug applications (ANDAs) and biologic license applications (BLAs).